Latest filing published 18 Jun 2025 for BioAtla, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Eddie Williams: trading record in brief
Eddie Williams (board member) discloses dealings in 2 companies, chiefly Gyre Therapeutics, Inc. and BioAtla, Inc. The record holds 20 filings, for trades running from 31 December 2018 to 18 June 2025.
The open-market record is one-sided, with 1 purchase worth €10k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 19 share grants.
Most recently, on 18 June 2025, the filings show a share grant in BioAtla, Inc. The last purchase on record was published on 4 March 2020, which is 2,441 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eddie Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,500 shares0Common StockSEC:0000950170-25-088064:0
- 16,500 shares0Common StockSEC:0000950170-24-073662:0
- 4,827 shares0Common StockSEC:0001209191-24-000603:0
- 6,985 shares0Common StockSEC:0001209191-23-051692:0
- 3,958 shares0Common StockSEC:0001209191-23-041217:0
- 4,430 shares0Common StockSEC:0001209191-23-029632:0
- 12,308 shares0Common StockSEC:0001209191-22-002488:0
- 2,980 shares0Common StockSEC:0001209191-21-059436:0
- 1,414 shares0Common StockSEC:0001209191-21-044693:0
9 of 9 declarations
